LONG-TERM THERAPY OF ELAGOLIX + ADD-BACK THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN FOR 48 MONTHS: A SAFETY UPDATE ON BONE MINERAL DENSITY DATA OF A PHASE 3 STUDY

James A. Simon, Jin Hee Kim, James W. Thomas, Juki Ng, Paul B. Miller, Anna Chan, Michael C. Snabes
In: Fertility and Sterility · 2023 · vol. 120(4) , pp. e62 · doi:10.1016/j.fertnstert.2023.08.206 · W4387410227
article OA: bronze CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This Phase 3 study extension evaluated the long-term safety of elagolix plus add-back therapy over 48 months in women with endometriosis-associated pain, focusing on bone mineral density changes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK